combretastatin has been researched along with Inflammation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, YC; Chen, PJ; Hwang, TL; Kashyap, HK; Kumar, S; Shen, YC; Wang, YH; Yu, HP | 1 |
| Greene, LM; Kinsella, P; Meegan, MJ; Nathwani, SM; O'Boyle, NM; Pollock, JK; Zisterer, DM | 1 |
2 other study(ies) available for combretastatin and Inflammation
| Article | Year |
|---|---|
Design and synthesis of β-carboline and combretastatin derivatives as anti-neutrophilic inflammatory agents.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Bibenzyls; Carbolines; Dose-Response Relationship, Drug; Drug Design; Humans; Inflammation; Molecular Structure; Neutrophils; Structure-Activity Relationship | 2021 |
Involvement of NF-κB in mediating the anti-tumour effects of combretastatins in T cells.
Topics: Antineoplastic Agents; Apoptosis; Bibenzyls; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; HEK293 Cells; Humans; Inflammation; Jurkat Cells; NF-kappa B; Signal Transduction; T-Lymphocytes | 2018 |